{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:07Z","timestamp":1792740487104,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.diagmicrobio.2020.115200","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:36:46Z","timestamp":1599133006000},"page":"115200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type"],"prefix":"10.1016","volume":"99","author":[{"given":"Paul R.","family":"Lephart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"LeBar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane W.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqaa097","article-title":"Clinical evaluation and utilization of multiple molecular in vitro diagnostic assays for the detection of SARS-CoV-2","author":"Cradic","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00798-20","article-title":"Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients","author":"Harrington","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0015","doi-asserted-by":"crossref","first-page":"104429","DOI":"10.1016\/j.jcv.2020.104429","article-title":"Evaluation of the COVID19 ID NOW EUA assay","volume":"128","author":"Mitchell","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00938-20","article-title":"Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2","author":"Moore","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00760-20","article-title":"Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19","author":"Rhoads","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/RTI.0000000000000533","article-title":"Diagnostic performance of chest x-ray for COVID-19 pneumonia during the SARS-CoV-2 pandemic in Lombardy Italy","author":"Schiaffino","year":"2020","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0035","doi-asserted-by":"crossref","first-page":"104428","DOI":"10.1016\/j.jcv.2020.104428","article-title":"Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche Cobas for the rapid detection of SARS-CoV-2","volume":"128","author":"Smithgall","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00630-20","article-title":"Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection","author":"Visseaux","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0045","doi-asserted-by":"crossref","first-page":"104426","DOI":"10.1016\/j.jcv.2020.104426","article-title":"Multi-center evaluation of Cepheid Xpert\u00ae Xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic","volume":"128","author":"Wolters","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2020.115200_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00783-20","article-title":"Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2","author":"Zhen","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320305770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320305770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:54:46Z","timestamp":1760003686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320305770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0732889320305770"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115200","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.04.135616","asserted-by":"object"}]},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115200"}}